ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006

Funding Opportunities: Department of Defense Ovarian Cancer Research

May 5, 2000

In Brief: Lasker Foundation Will Not Make 1990 Awards; Michigan Cancer Elects Fischer Vice Chairman

March 2, 1990

NSABP Accrual To Resume Soon; Group ponders Elections, Move To Fox Chase

May 27, 1994

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975

NCI May Support More Training Of Cancer Surgeons

May 23, 1975